Equities Research Analysts’ Updated EPS Estimates for February 9th (AARD, AFRM, BVS, CNC, DAVE, DBD, DEVO, ENTX, ERIC, ESLA)

Equities Research Analysts’ updated eps estimates for Monday, February 9th:

Aardvark Therapeutics (NASDAQ:AARD) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $40.00 target price on the stock.

Affirm (NASDAQ:AFRM) had its overweight rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $85.00 target price on the stock.

Barrington Research initiated coverage on shares of Bioventus (NYSE:BVS). Barrington Research issued an outperform rating and a $13.00 price target on the stock.

Centene (NYSE:CNC) had its neutral rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $41.00 target price on the stock.

Keefe, Bruyette & Woods assumed coverage on shares of Dave (NASDAQ:DAVE). Keefe, Bruyette & Woods issued an outperform rating on the stock.

Diebold Nixdorf (NYSE:DBD) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $80.00 price target on the stock.

Devolver Digital (LON:DEVO) had its hold rating reissued by analysts at Shore Capital Group Ltd.

Entera Bio (NASDAQ:ENTX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $10.00 price target on the stock.

Morgan Stanley began coverage on shares of Ericsson (NASDAQ:ERIC). Morgan Stanley issued an equal weight rating and a $11.00 price target on the stock.

Estrella Immunopharma (NASDAQ:ESLA) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $8.00 target price on the stock.

Essex Property Trust (NYSE:ESS) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $290.00 price target on the stock.

Fold (NASDAQ:FLD) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $7.00 target price on the stock.

Frasers Group (LON:FRAS) had its hold rating reissued by analysts at Shore Capital Group Ltd.

Citizens Jmp started coverage on shares of Fermi (NASDAQ:FRMI). Citizens Jmp issued a market outperform rating and a $30.00 target price on the stock.

Alphabet (NASDAQ:GOOGL) had its buy rating reissued by analysts at JPMorgan Chase & Co..

Robinhood Markets (NASDAQ:HOOD) had its overweight rating reissued by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $130.00 price target on the stock.

Immunic (NASDAQ:IMUX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $8.00 price target on the stock.

Kyndryl (NYSE:KD) had its market perform rating reaffirmed by analysts at Oppenheimer Holdings, Inc..

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) had its buy rating reissued by analysts at D. Boral Capital. D. Boral Capital currently has a $2.00 price target on the stock.

Morgan Stanley initiated coverage on shares of Marathon Digital (NASDAQ:MARA). The firm issued an underweight rating and a $8.00 price target on the stock.

MoonLake Immunotherapeutics (NASDAQ:MLTX) had its buy rating reiterated by analysts at BTIG Research. They currently have a $24.00 price target on the stock.

M&G (LON:MNG) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 342 price target on the stock.

Morgan Stanley started coverage on shares of Nokia (NYSE:NOK). Morgan Stanley issued an overweight rating and a $8.00 price target on the stock.

NatWest Group (LON:NWG) had its sector perform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 725 target price on the stock.

NatWest Group (LON:NWG) had its hold rating reiterated by analysts at Shore Capital Group Ltd.

Pan African Resources (LON:PAF) had its buy rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 154 target price on the stock.

PDF Solutions (NASDAQ:PDFS) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $34.00 target price on the stock.

Evercore ISI initiated coverage on shares of Palomar (NASDAQ:PLMR). They issued an outperform rating and a $150.00 price target on the stock.

Porvair (LON:PRV) had its hold rating reiterated by analysts at Shore Capital Group Ltd.

Lake Street Capital initiated coverage on shares of QuickLogic (NASDAQ:QUIK). They issued a buy rating and a $10.00 target price on the stock.

Rainbow Rare Earths (LON:RBW) had its buy rating reaffirmed by analysts at Berenberg Bank.

Solid Biosciences (NASDAQ:SLDB) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $16.00 target price on the stock.

Leerink Partners started coverage on shares of Terns Pharmaceuticals (NASDAQ:TERN). The firm issued an outperform rating and a $58.00 target price on the stock.

Vir Biotechnology (NASDAQ:VIR) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $14.00 price target on the stock.

Ventas (NYSE:VTR) had its overweight rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $93.00 price target on the stock.

Warpaint London (LON:W7L) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 510 price target on the stock.

Western Digital (NASDAQ:WDC) had its outperform rating reissued by analysts at Wedbush. Wedbush currently has a $325.00 target price on the stock.

Westlake (NYSE:WLK) had its neutral rating reaffirmed by analysts at Mizuho. Mizuho currently has a $88.00 price target on the stock.

Wedbush began coverage on shares of Zura Bio (NASDAQ:ZURA). They issued an outperform rating and a $15.00 price target on the stock.